Given the potential therapeutic benefits of regulating serine/arginine‐rich splicing factor 3 (SRSF3) in CRC, silencing SRSF3 has been shown to significantly suppress CRC cell proliferation and migration by inhibiting its target gene, DHCR24. This evidence concerns the gene SRSF3 and colorectal carcinoma.